The company is now offering its testing diagnostics products to inmates 

who are willing to successfully reintegrate into society

San Diego, CA (August 2, 2021) - Phamatech, a SAMHSA-certified laboratory and global manufacturer of testing devices, announced the signing of a new contract with the Pennsylvania Department of Corrections (PA DOC). The company has become a supplier of its QuickScreen integrated products to 24 parole offices throughout the state. 

Being the only manufacturer and laboratory of its kind nationwide, Phamatech is uniquely qualified to provide its products for random drug testing, which is a routine part of parole supervision. As a part of the contract, the company offers two varieties of multiple panel urine cup tests and one type of dip panel tests. 

“Our goal has always been to make testing available to everyone, and we are honored that Phamatech will now play an important role in helping Pennsylvania reentrants become drug free”, - said Arthur Jensen, Vice President of Sales of Phamatech.

The PA DOC is always looking for effective methods to aid reentrants who are returning to society. “We believe our drug testing products will play a crucial role in keeping accountable those reentrants who are trying to transition from prison to regular life. Phamatech products have already proven to be an effective tool for reentrants who choose to live a drug-free life.”, - said Annette Adair, Special Accounts Manager at Phamatech.

Phamatech has been working with the Federal Bureau of Prisons since 2008 and the PA DOC since 2014.  


Phamatech Inc., a CLIA licensed laboratory since 2008, has been manufacturing diagnostic products for over 25 years and has over 100 FDA approved tests. Phamatech offers pre-employment drug testing, DOT testing, and forensic testing to local businesses and organizations.

For media inquiries, contact:

Sharda Veeramally

10 to 1 Public Relations


Josh Weiss

10 to 1 Public Relations


If you have any questions, please reach out to our sales team, at or by calling us at 858-643-5555.

Comments are closed.